NCT03239626View on ClinicalTrials.gov

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

April 28, 2025

Study Completion Date

April 28, 2025

Conditions
Cervix CancerRadiotherapy, AdjuvantRadiotherapy, Intensity-ModulatedHypofractionated Dose
Interventions
RADIATION

POHIM-RT

postoperative adjuvant IMRT with hypofractionation (2.5 Gy/fraction, 16 fractions, once a day)

Trial Locations (1)

06351

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT03239626 - Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer | Biotech Hunter | Biotech Hunter